European Malignant Hyperthermia Group
  • About
  • News Meetings Education 2026 annual meeting
  • General Testing for MH Genetics PatientInformation
  • Recommendations
  • Grants
  • MH units
  • Contact
  • Links
  • Find
  • Sign In My Account
European Malignant Hyperthermia Group
  • About/
  • News & meetings/
    • News
    • Meetings
    • Education
    • 2026 annual meeting
  • Diagnosis/
    • General
    • Testing for MH
    • Genetics
    • PatientInformation
  • Recommendations/
  • Grants/
  • MH units/
  • Contact/
  • Links/
  • Find/
  • Sign InMy Account
European Malignant Hyperthermia Group

Recommendations

European Malignant Hyperthermia Group
  • About/
  • News & meetings/
    • News
    • Meetings
    • Education
    • 2026 annual meeting
  • Diagnosis/
    • General
    • Testing for MH
    • Genetics
    • PatientInformation
  • Recommendations/
  • Grants/
  • MH units/
  • Contact/
  • Links/
  • Find/
  • Sign InMy Account

Recommendations

In addition to the guidelines for MH diagnosis the European Malignant Hyperthermia Group has issued the following recommendations. Previous recommendations can be found here.


Featured
January 6, 2025
Use of Penthrox (methoxyflurane)
January 6, 2025
January 6, 2025
November 4, 2024
Recognising and managing a malignant hyperthermia crisis (v2024)
November 4, 2024
November 4, 2024
May 9, 2024
Life insurance and MH
May 9, 2024
May 9, 2024
August 26, 2020
Dantrolene availability
August 26, 2020
August 26, 2020
July 28, 2020
Occupational exposure to volatile anaesthetics
July 28, 2020
July 28, 2020
May 20, 2019
Malignant hyperthermia during pregnancy
May 20, 2019
May 20, 2019
February 27, 2018
Perioperative Management of MH Suspected or Susceptible Patients
February 27, 2018
February 27, 2018

January 19, 2021

Perioperative management of known or suspected MHS

January 19, 2021/ Thierry Girard

We are pleased to announce publication of the EMHG guidance on perioperative management of malignant hyperthermia suspected or susceptible patients.

https://doi.org/10.1016/j.bja.2020.09.029

Screenshot 2021-01-19 at 13.04.57.png
January 19, 2021/ Thierry Girard/
previous_guidelines

Thierry Girard

February 27, 2018

Preparation of Anaesthetic Workstations for MH suspected or susceptible patients

February 27, 2018/ Thierry Girard

Three options to prepare an anaesthetic workstation for MH suspected or MH susceptible patients.

Read More
February 27, 2018/ Thierry Girard/
previous_guidelines
December 30, 2017

in-vitro contracture testing

December 30, 2017/ Thierry Girard

In addition to the guideline for the investigation of MH susceptibility, there are the following recommendations:

  • Ryanodine muscle contracture testing (optional test)

  • 4-chloro-m-kresol bolus test

  • Cryopreservation of muscle tissue

December 30, 2017/ Thierry Girard/
previous_guidelines

Thierry Girard

  • About/
  • News & meetings/
    • News
    • Meetings
    • Education
    • 2026 annual meeting
  • Diagnosis/
    • General
    • Testing for MH
    • Genetics
    • PatientInformation
  • Recommendations/
  • Grants/
  • MH units/
  • Contact/
  • Links/
  • Find/
  • Sign InMy Account

European Malignant Hyperthermia Group

EMHG

The EMHG constitution
The Executive Committee
Quality Assurance Program
Membership
Contact us


signup for membership

Specialist society member

privacy policy